Cargando…
Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists
PURPOSE: Low- and middle-income countries (LMICs) experience the burden of 80% of new childhood cancer cases worldwide, with cure rates as low as 10% in some countries. Metronomics combines frequent administrations of low-dose chemotherapy with drug repurposing, which consists of using already-appro...
Autores principales: | Revon-Rivière, Gabriel, Banavali, Shripad, Heississen, Laila, Gomez Garcia, Wendy, Abdolkarimi, Babak, Vaithilingum, Manickavallie, Li, Chi-Kong, Leung, Ping Chung, Malik, Prabhat, Pasquier, Eddy, Epelman, Sidnei, Chantada, Guillermo, André, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613668/ https://www.ncbi.nlm.nih.gov/pubmed/31260397 http://dx.doi.org/10.1200/JGO.18.00244 |
Ejemplares similares
-
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
por: Banavali, Shripad, et al.
Publicado: (2015) -
Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014) -
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study
por: Pasquier, Eddy, et al.
Publicado: (2016) -
Metronomics: Intrinsic Anakoinosis Modulator?
por: Nicolas, André, et al.
Publicado: (2018) -
Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai
por: Pantziarka, Pan, et al.
Publicado: (2016)